These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2381970)

  • 21. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
    Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
    Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New analytical techniques to facilitate preformulation screening in propellant systems.
    Mogalian E; Kuehl PJ; Myrdal PB
    Int J Pharm; 2007 Aug; 340(1-2):223-9. PubMed ID: 17498897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the use of novel drug delivery systems for antiretroviral drugs.
    Ojewole E; Mackraj I; Naidoo P; Govender T
    Eur J Pharm Biopharm; 2008 Nov; 70(3):697-710. PubMed ID: 18655830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Crystallographic behavior of carbamazepine preparations under compression pressure].
    Kala H; Haack U; Fahr F; Pollandt P
    Pharmazie; 1986 Jan; 41(1):61-2. PubMed ID: 3960954
    [No Abstract]   [Full Text] [Related]  

  • 25. Taxol: a history of pharmaceutical development and current pharmaceutical concerns.
    Adams JD; Flora KP; Goldspiel BR; Wilson JW; Arbuck SG; Finley R
    J Natl Cancer Inst Monogr; 1993; (15):141-7. PubMed ID: 7912520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of compounding and storage conditions on stability of pergolide mesylate.
    Davis JL; Kirk LM; Davidson GS; Papich MG
    J Am Vet Med Assoc; 2009 Feb; 234(3):385-9. PubMed ID: 19210262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation and in vitro/in vivo investigation of carbamazepine controlled-release matrix tablets.
    Ikinci G; Capan Y; Senel S; Dalkara T; Hincal AA
    Pharmazie; 1999 Feb; 54(2):139-41. PubMed ID: 10084159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The compression of granulates containing solid dispersions.
    Kinget R; Kemel R
    Pharmazie; 1985 Jul; 40(7):475-7. PubMed ID: 4048252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stabilization of the maleate salt of a basic drug by adjustment of microenvironmental pH in solid dosage form.
    Zannou EA; Ji Q; Joshi YM; Serajuddin AT
    Int J Pharm; 2007 Jun; 337(1-2):210-8. PubMed ID: 17296277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relations between several polymorphic forms and the dihydrate of carbamazepine.
    Krahn FU; Mielck JB
    Pharm Acta Helv; 1987; 62(9):247-54. PubMed ID: 3423093
    [No Abstract]   [Full Text] [Related]  

  • 32. [Rate of dissolution and polymorphism of carbamazepine: different prescriptions].
    Lefebvre C; Guyot-Hermann AM; Draguet-Brughmans M; Bouché R
    Pharm Acta Helv; 1987; 62(12):341-7. PubMed ID: 3441480
    [No Abstract]   [Full Text] [Related]  

  • 33. [Polyols-pharmaceutical and toxicological characteristics. I].
    Dominguez-Gil A; Cadorniga R
    Farmaco Prat; 1971 Jul; 26(7):394-404. PubMed ID: 5561804
    [No Abstract]   [Full Text] [Related]  

  • 34. [Storage times for stabilizers used to prepare solutions for injection].
    Kozlova IG; Tamarskaia VV
    Farm Zh; 1978; (3):41. PubMed ID: 680105
    [No Abstract]   [Full Text] [Related]  

  • 35. The use of radioisotopically labelled compounds in drug substance and formulated product stability studies. II. Application to pharmaceutical formulations.
    Hudson HE; Jones MF
    Analyst; 1972 Sep; 97(158):726-7. PubMed ID: 5075673
    [No Abstract]   [Full Text] [Related]  

  • 36. Formulating cysteamine injection.
    Prior FG
    Lancet; 1977 Feb; 1(8006):315. PubMed ID: 64848
    [No Abstract]   [Full Text] [Related]  

  • 37. Formulation and evaluation of aceclofenac injection made by mixed hydrotropic solubilization technique.
    Kumar Maheshwari R; Indurkhya A
    Iran J Pharm Res; 2010; 9(3):233-42. PubMed ID: 24363732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative estimation of diacerein in bulk and in capsule formulation using hydrotropic solubilizing agents by UV-spectrophotometry and the first order derivative using the area under curve method.
    Pandey R; Patil PO; Patil MU; Deshmukh PK; Bari SB
    Pharm Methods; 2012 Jan; 3(1):4-8. PubMed ID: 23781470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New spectrophotometric estimation of indomethacin capsules with niacinamide as hydrotropic solubilizing agent.
    Maheshwari RK; Rathore A; Agrawal A; Gupta MA
    Pharm Methods; 2011 Jul; 2(3):184-8. PubMed ID: 23781453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel application of hydrotropic solubilizing additives in the estimation of aspirin in tablets.
    Maheshwari RK; Saxena M; Gahlot M; Chaki R; Kinariwala M; Jagwani Y
    Indian J Pharm Sci; 2010 Sep; 72(5):649-51. PubMed ID: 21695002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.